Approval: 2017
Human pharmacokinetic studies show ipamorelin achieves peak GH release approximately 40 minutes postdose [8]
We detected a lower arginine/proline media ratio (lower metabolite concentrations in arginine medium compared to proline medium) for 2-oxoglutarate, linoleate, 11,14-eicosadienote, proline, 2-aminoadipate, pyroglutamate, para-toluate, 2-aminobutyrate, lysine, glutamine, alanine, glutamate, serine, and margarate in gdh3 / gdh3 mutants compared to wild-type
Potentially first-in-Class Anti-Myostatin Approach: Blocks myostatin (GDF8), a negative regulator of muscle growth, to preserve and enhance lean mass